Lefosse, BMA and others advises on Nagro Series B1 funding

Lefosse, acting alongside Clifford Chance as international counsel, advised Rabo Partnerships on its equity investment in Nagro as part of the company’s Series B funding round. BMA and Campbells acted for Nagro.

The transaction involved a EUR 7 million capital injection, corresponding to the first tranche (Series B1) of a Series B round expected to reach up to EUR 10 million in total new capital.

Rabo Partnerships, the strategic investment arm of the Rabobank Group, acted as lead investor, with Itaú Ventures Fundo de Investimento em Participações Multiestratégia – Investimento no Exterior participating as an existing investor. The investment strengthens Nagro’s capital structure to accelerate its growth strategy and resulted in the dilution of existing shareholders.

Nagro is a Brazilian financial services company providing credit and technology-enabled financial solutions to farmers and agribusinesses, operating in a sector subject to supervision by the Central Bank of Brazil (BACEN). The transaction aligns with Rabo Partnerships’ mandate to expand financial access in the food and agriculture sector, particularly in rural and underserved communities in emerging markets.

Lefosse relied on partners Fernando Carvalho (pictured left) and Kenneth Ferreira; associates João Pedro Pizarro, Marcio Meinberg, and Beatriz Salotti.

Also advising Rabo Partnerships:
Clifford Chance (Amsterdam) relied on Tim Heerschop, Sabine van den Heuvel and Jasper Leistra.
Mourant relied on Mali Bongers and Andrew B. Grant

BMA – Barbosa Müssnich Aragão advised Nagro and relied on partners Ian Bussinger (pictured right), Luis Henrique Costa and lawyer Felipe Pinto Duarte Sbané.

Campbells also advised Nagro and relied on Sayak Bhattacharya.

In-house counsel
Rabo Partnerships: Martin Luijt and Iris Hendriks.